Plain-English translation of NCT06012097 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether an can help reduce pain from De Quervain disease—a condition that causes inflammation in the tendons on the thumb side of your wrist. You would apply the medication (or a standard anti-inflammatory gel if you're in the comparison group) along with wearing a supportive splint. The researchers want to see if this natural approach works as well as or better than the usual treatments.
De Quervain disease is common, especially among new mothers and people who use their hands a lot, and current treatments with anti-inflammatory gels or steroid injections can cause unwanted side effects. This study explores whether this medication offers a gentler alternative that still relieves pain effectively.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to apply either the or a standard anti-inflammatory gel to your wrist, along with wearing a supportive splint for your thumb and wrist. Throughout the study, you would apply the treatment as directed and visit the hospital periodically so researchers can measure your pain levels and track how well the treatment is working. The study involves 70 participants total and is currently recruiting patients.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
France